<?xml version="1.0" encoding="UTF-8"?>
<p id="para0038">Other potentially interesting treatments currently being studied include the use of emapalumab (anti-interferon-Î³ monoclonal antibody Sobi-IMMUNO-101 study) and the antiparasitic ivermectin 
 <xref rid="bib0049" ref-type="bibr">[48]</xref>.
</p>
